Biovie Inc Stock Price To Earning
| BIVI Stock | USD 2.82 0.18 6.00% |
Biovie Inc fundamentals help investors to digest information that contributes to Biovie's financial success or failures. It also enables traders to predict the movement of Biovie Stock. The fundamental analysis module provides a way to measure Biovie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biovie stock.
Biovie |
Biovie Inc Company Price To Earning Analysis
Biovie's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Biovie Price To Earning | 18.12 X |
Most of Biovie's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biovie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Biovie Inc has a Price To Earning of 18.12 times. This is 29.88% lower than that of the Biotechnology sector and 267.55% higher than that of the Health Care industry. The price to earning for all United States stocks is 36.91% higher than that of the company.
Biovie Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biovie's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biovie could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics of similar companies.Biovie is currently under evaluation in price to earning category among its peers.
Biovie Fundamentals
| Return On Equity | -2.08 | ||||
| Return On Asset | -0.67 | ||||
| Current Valuation | 37 M | ||||
| Shares Outstanding | 17.77 M | ||||
| Shares Owned By Insiders | 13.69 % | ||||
| Shares Owned By Institutions | 9.98 % | ||||
| Number Of Shares Shorted | 1.92 M | ||||
| Price To Earning | 18.12 X | ||||
| Price To Book | 3.79 X | ||||
| EBITDA | (31.95 M) | ||||
| Net Income | (32.12 M) | ||||
| Cash And Equivalents | 18.64 M | ||||
| Cash Per Share | 0.62 X | ||||
| Total Debt | 6.11 M | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.50 X | ||||
| Book Value Per Share | 2.50 X | ||||
| Cash Flow From Operations | (27.95 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (5.08) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 53.3 M | ||||
| Total Asset | 25.21 M | ||||
| Retained Earnings | (334.23 M) | ||||
| Working Capital | 19.55 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 961 K | ||||
| Net Asset | 25.21 M |
About Biovie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biovie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:Check out Biovie Piotroski F Score and Biovie Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.